We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+4.44%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
AUM
$391M
AUM Growth
+$67.7M
Cap. Flow
+$29.8M
Cap. Flow %
7.62%
Top 10 Hldgs %
31.31%
Holding
78
New
9
Increased
36
Reduced
29
Closed
4

Sector Composition

1 Consumer Discretionary 19.23%
2 Industrials 19.07%
3 Technology 18%
4 Consumer Staples 12.14%
5 Healthcare 12.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
26
Nike
NKE
$64.8B
$7.51M 1.92%
136,211
-329
-0.2% -$19.9K
AME icon
27
Ametek
AME
$54.2B
$7.36M 1.88%
135,771
-1,255
-0.9% -$59.8K
VAR
28
DELISTED
Varian Medical Systems, Inc.
VAR
$6.6M 1.69%
82,444
+3,674
+5% +$250K
EV
29
DELISTED
Eaton Vance Corp.
EV
$6.37M 1.63%
145,953
+3,620
+3% +$108K
DLTR icon
30
Dollar Tree
DLTR
$24.3B
$6.11M 1.56%
78,293
-3,167
-4% -$250K
SLGN icon
31
Silgan Holdings
SLGN
$4.96B
$6.04M 1.54%
207,096
-290
-0.1% -$7.53K
CNI icon
32
Canadian National Railway
CNI
$78B
$5.77M 1.47%
78,048
+12,872
+20% +$721K
PII icon
33
Polaris
PII
$4.13B
$5.71M 1.46%
71,055
+15,643
+28% +$1.36M
ORLY icon
34
O'Reilly Automotive
ORLY
$71.3B
$5.65M 1.44%
333,000
+112,260
+51% +$1.92M
SYK icon
35
Stryker
SYK
$122B
$5.64M 1.44%
43,131
-1,924
-4% -$190K
K
36
DELISTED
Kellanova
K
$4.47M 1.14%
65,753
-2,736
-4% -$189K
ABBV icon
37
AbbVie
ABBV
$453B
$4.31M 1.1%
66,185
-2,483
-4% -$138K
NVO
38
Novo Nordisk
NVO
$223B
$4.21M 1.08%
238,066
+44,946
+23% +$1.2M
COL
39
DELISTED
Rockwell Collins
COL
$4.03M 1.03%
40,370
-1,034
-2% -$89.7K
OA
40
DELISTED
Orbital ATK, Inc.
OA
$3.08M 0.79%
32,023
-6,101
-16% -$518K
LH icon
41
Labcorp
LH
$23.2B
$2.96M 0.76%
23,921
-710
-3% -$68.1K
KMB icon
42
Kimberly-Clark
KMB
$35.9B
$2.95M 0.75%
22,538
-698
-3% -$90.8K
HBI
43
DELISTED
Hanesbrands
HBI
$2.87M 0.73%
138,307
+49,067
+55% +$1.4M
PDCO
44
DELISTED
Patterson Companies, Inc.
PDCO
$2.74M 0.7%
61,427
-4,479
-7% -$194K
ALK icon
45
Alaska Air
ALK
$5.07B
$2.52M 0.64%
+28,159
New +$2.08M
LLY icon
46
Eli Lilly
LLY
$1.05T
$2.49M 0.64%
29,189
-1,841
-6% -$139K
AON icon
47
Aon
AON
$78.5B
$2.48M 0.63%
+20,769
New +$1.95M
EXPD icon
48
Expeditors International
EXPD
$23.9B
$2.45M 0.63%
43,422
+4,732
+12% +$217K
DHR icon
49
Danaher
DHR
$145B
$2.43M 0.62%
42,003
-8,692
-17% -$518K
MTD icon
50
Mettler-Toledo International
MTD
$26.4B
$1.85M 0.47%
3,852
-263
-6% -$84.6K

Similar funds

JLB & Associates's Q1 2016 Portfolio in Review

As of Q1 2016, JLB & Associates held 78 positions worth $391M, up 21% from $324M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

JLB & Associates deployed $29.8M of net new capital in Q1 2016, opening 9 new positions and adding to 36 existing holdings. Its largest new stake was Alaska Air: 28,159 shares worth $2.52M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Vista Outdoor Inc., an estimated $2.17M trimmed.

  • JLB & Associates's largest Q1 2016 buy was Alaska Air: 28,159 shares worth $2.52M.
  • JLB & Associates added most to Toro Company in Q1 2016, an estimated $8.7M increase.
  • JLB & Associates's biggest Q1 2016 reduction was Vista Outdoor Inc., cutting an estimated $2.17M.
  • JLB & Associates fully exited Core Laboratories in Q1 2016, selling an estimated $2.01M.
  • JLB & Associates's ten largest holdings make up 31% of its $391M portfolio in Q1 2016.
  • JLB & Associates opened 9 new positions and closed 4 in Q1 2016.
  • JLB & Associates's portfolio value rose 21% quarter-over-quarter to $391M.

Based on JLB & Associates's 13F filing for Q1 2016, filed 8 Apr 2016.